This is a task order awarded by the Food and Drug Administration (FDA) to Digim Solution LLC, a minority-owned small business, under an indefinite-delivery, indefinite-quantity (IDIQ) contract. The task order is for 3D microscopy, AI-based quantification, and modeling to support non-clinical evaluation and regulatory submissions for complex injectable and insertable drug products. The task order has a firm fixed price of $360,000.00 and a period of performance through March 9, 2026. Digim Solution LLC has previously received multiple contract awards from the Department of Health and Human Services agencies, including the FDA and Centers for Disease Control and Prevention, for advanced product characterization, AI analysis, and microstructure evaluation. This task order is not associated with a set-aside designation.
Generated 12/5/24, 10:10 AM